New Evidence With BTK Inhibitor Therapy in CLL and MCL From SOHO 2023
Gain insight into expert perspectives from Catherine C. Coombs, MD, MS, and Toby Eyre, MBChB, MD, as they discuss recent key studies from SOHO 2023 on BTK inhibition in chronic lymphocytic leukemia and mantle cell lymphoma and the potential implications for clinical practice.